Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo
- 1Section of Pulmonary Diseases, Critical Care and Environmental Medicine, John W. Deming Department of Medicine, Tulane University, New Orleans, LA, USA
- 2Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 3Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Abstract
Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states.
Key features
• Programmable sesRNAs convert endogenous RNA signatures into ADAR-dependent EGFP translation without requiring a new transgenic mouse line.
• Includes candidate sensor design, in vitro validation of target-dependent EGFP expression in HEK293T cells, and AAV6.2FF production and purification using a heparin column.
• Supports in vivo labeling of AT2, AT1, and Sprr1a-positive transitional alveolar epithelial cells in mice.
• Extends the workflow to human IPF PCLS for ex vivo assessment of SPRR1A-guided reporter expression in KRT17+KRT5- aberrant basaloid cells.
Related
- Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis
- Pulmonary Fibroblast Heterogeneity and Functional Remodeling in Idiopathic Pulmonary Fibrosis: State Persistence and Reversibility
- A mucosal barrier injury related six gene transcriptomic signature associated with ulcerative colitis using machine learning and public transcriptomic data
- Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.
- IPF distal lung epithelial cells acquire a DNA methylation signature consistent with activation of basal cell transcriptional programs
BibTeX
@article{zheng2026transcriptomic,
title = {{Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo}},
author = {Zhen Zheng and Chun-sun Jiang and Dan Shan and Chao He and Ivan O. Rosas and Joseph A. Lasky and Victor J. Thannickal and Yong Zhou},
journal = {Bio-protocol},
year = {2026},
month = nov,
doi = {10.21769/bioprotoc.5863},
url = {https://doi.org/10.21769/bioprotoc.5863},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo
AU - Zhen Zheng
AU - Chun-sun Jiang
AU - Dan Shan
AU - Chao He
AU - Ivan O. Rosas
AU - Joseph A. Lasky
AU - Victor J. Thannickal
AU - Yong Zhou
PY - 2026
DA - 2026/11/05
JO - Bio-protocol
DO - 10.21769/bioprotoc.5863
UR - https://doi.org/10.21769/bioprotoc.5863
AB - Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states. Key features • Programmable sesRNAs convert endogenous RNA signatures into ADAR-dependent EGFP translation without requiring a new transgenic mouse line. • Includes candidate sensor design, in vitro validation of target-dependent EGFP expression in HEK293T cells, and AAV6.2FF production and purification using a heparin column. • Supports in vivo labeling of AT2, AT1, and Sprr1a-positive transitional alveolar epithelial cells in mice. • Extends the workflow to human IPF PCLS for ex vivo assessment of SPRR1A-guided reporter expression in KRT17+KRT5- aberrant basaloid cells.
SN - 2331-8325
ER -